04:52 PM EDT, 06/24/2025 (MT Newswires) -- Forte Biosciences ( FBRX ) said late Tuesday that it has started an underwritten public offering of shares to raise funds for working capital and general corporate purposes.

Investors can buy pre-funded warrants in lieu of stock, the company said. It also expects to grant its underwriters an over-allotment option.

The shares were down over 11% in extended trading.